FIELD: chemistry.
SUBSTANCE: invention relates to use of 3,11b-cis-dihydrotetrabenazine or its pharmaceutically acceptable salts to prepare a medicinal agent for preventing or treating schizophrenia. The invention also relates to compounds for use in preventing or treating psychosis, methods of preventing or treating psychosis, as well as methods of preventing or alleviating a psychotic episode.
EFFECT: use of 3,11b-cis-dihydrotetrabenazine to prepare a medicinal agent for preventing or treating schizophrenia.
34 cl, 7 ex, 6 tbl, 4 dwg
| Title |
Year |
Author |
Number |
| DIHYDROTETRABENAZENES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
2005 |
- Tridzhett Robert
- Klark Jan
- Tertl Robert
- Dzhonston Grant
|
RU2365590C2 |
| 3,11b-CIS-DIHYDROTETRABENAZINE FOR TREATMENT OF PROLIFERATIVE DISEASE OR INFLAMMATION |
2006 |
|
RU2409364C2 |
| APPLICATION OF 3,11b-CIS-DIHYDROTETRABENAZINE FOR TREATMENT OF HUNTINGTON'S DISORDER SYMPTOMS |
2006 |
- Tridzhett Robert
- Fiju T'Erri
|
RU2409365C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR, AND THEIR USE |
2015 |
- Khoar Semyuel Rodzher Dzhess
|
RU2757221C2 |
| CYCLOPROPYLPIPERIDINE GLYCINE TRANSPORTER INHIBITORS |
2005 |
- Lindsli Krejg U.
- Uisnoski Dehvid D.
- Uolkenberg Skott Eh.
|
RU2387644C2 |
| PHARMACEUTICAL COMPOSITIONS |
2018 |
- Duffield, Andrew John
- Pandya, Anant
|
RU2783865C2 |
| (+)-ALPHA-DIHYDROTETRABENAZINE FOR USE IN TREATMENT OF MOTOR DISORDER |
2018 |
- Duffield, Andrew John
- Pandya, Anant
|
RU2771164C2 |
| TREATMENT OF HYPERKINETIC MOTOR DISORDERS |
2015 |
|
RU2753740C2 |
| USE OF (−)-α-DIHYDROTETRABENAZINE OR A COMBINATION THEREOF WITH (+)-α-DIHYDROTETRABENAZINE IN THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDER, AS WELL AS CORRESPONDING METHODS |
2018 |
- Duffield, Andrew John
- Pandya, Anant
|
RU2768738C2 |
| THERAPEUTIC AGENTS |
2008 |
- Bilodo Mark T.
- Nanda Kausik K.
- Trotter B. Uehsli
|
RU2468025C2 |
